A biologic risk model for stage I lung cancer : Immunohistochemical analysis of 408 patients with the use of ten molecular markers. Discussion
- Author
- D'AMICO, T. A1 ; MASSEY, M1 ; HERNDON, J. E1 ; MOORE, M.-B1 ; HARPOLE, D. H1 ; BENFIELD, J. R
[1] Thoracic Oncology Program, Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, NC, United States - Conference name
- Annual Meeting of the Western Thoracic Surgical Association (24 ; Whistler, British Columbia 1998-06-24)
- Source
Journal of thoracic and cardiovascular surgery. 1999, Vol 117, Num 4, pp 736-743 ; ref : 26 ref
- CODEN
- JTCSAQ
- ISSN
- 0022-5223
- Scientific domain
- Anesthesia, intensive care; Cardiology, blood circulation, phlebology; Pneumology
- Publisher
- Elsevier, Philadelphia, PA
- Publication country
- United States
- Document type
- Conference Paper
- Language
- English
- Keyword (fr)
- Apoptose Bronchopulmonaire Classification par stade Cycle cellulaire Etude longitudinale Facteur croissance épiderme Homme Immunohistochimie Marqueur biologique Pronostic Survie Tumeur maligne Anatomopathologie Angiogenèse Appareil respiratoire pathologie Bronche pathologie Poumon pathologie
- Keyword (en)
- Apoptosis Bronchopulmonary Stage classification Cell cycle Follow up study Epidermal growth factor Human Immunohistochemistry Biological marker Prognosis Survival Malignant tumor Pathology Angiogenesis Respiratory disease Bronchus disease Lung disease
- Keyword (es)
- Apoptosis Broncopulmonar Clasificación por etapas Ciclo celular Estudio longitudinal Factor crecimiento epidermi Hombre Inmunohistoquímica Marcador biológico Pronóstico Sobrevivencia Tumor maligno Anatomía patológica Angiogénesis Aparato respiratorio patología Bronquio patología Pulmón patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11A Tumors of the respiratory system and mediastinum
- Discipline
- Pulmonology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 1753288
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/S0022-5223(99)70294-1 
https://dx.doi.org/10.1016/S0022-5223(99)70294-1
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0022-5223(99)70294-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"A biologic risk model for stage I lung cancer : Immunohistochemical analysis of 408 patients with the use of ten molecular markers. Discussion\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Journal of thoracic and cardiovascular surgery\";s:9:\"\u0000*\u0000stitle\";s:27:\"J. thorac. cardiovasc. surg\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:3:\"117\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"736\";s:8:\"\u0000*\u0000epage\";s:3:\"743\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-5223\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"D'AMICO\";s:10:\"\u0000*\u0000aufirst\";s:4:\"T. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:9:\"MASSEY, M\";i:1;s:13:\"HERNDON, J. E\";i:2;s:11:\"MOORE, M.-B\";i:3;s:13:\"HARPOLE, D. H\";i:4;s:14:\"BENFIELD, J. R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JTCSAQ\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"A biologic risk model for stage I lung cancer : Immunohistochemical analysis of 408 patients with the use of ten molecular markers. Discussion\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0022-5223(99)70294-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"A biologic risk model for stage I lung cancer : Immunohistochemical analysis of 408 patients with the use of ten molecular markers. Discussion\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Journal of thoracic and cardiovascular surgery\";s:9:\"\u0000*\u0000stitle\";s:27:\"J. thorac. cardiovasc. surg\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:3:\"117\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"736\";s:8:\"\u0000*\u0000epage\";s:3:\"743\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-5223\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"D'AMICO\";s:10:\"\u0000*\u0000aufirst\";s:4:\"T. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:9:\"MASSEY, M\";i:1;s:13:\"HERNDON, J. E\";i:2;s:11:\"MOORE, M.-B\";i:3;s:13:\"HARPOLE, D. H\";i:4;s:14:\"BENFIELD, J. R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JTCSAQ\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"A biologic risk model for stage I lung cancer : Immunohistochemical analysis of 408 patients with the use of ten molecular markers. Discussion\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0022-5223(99)70294-1\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0022-5223(99)70294-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"A biologic risk model for stage I lung cancer : Immunohistochemical analysis of 408 patients with the use of ten molecular markers. Discussion\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Journal of thoracic and cardiovascular surgery\";s:9:\"\u0000*\u0000stitle\";s:27:\"J. thorac. cardiovasc. surg\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:3:\"117\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"736\";s:8:\"\u0000*\u0000epage\";s:3:\"743\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-5223\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"D'AMICO\";s:10:\"\u0000*\u0000aufirst\";s:4:\"T. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:9:\"MASSEY, M\";i:1;s:13:\"HERNDON, J. E\";i:2;s:11:\"MOORE, M.-B\";i:3;s:13:\"HARPOLE, D. H\";i:4;s:14:\"BENFIELD, J. R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JTCSAQ\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"A biologic risk model for stage I lung cancer : Immunohistochemical analysis of 408 patients with the use of ten molecular markers. Discussion\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0022-5223(99)70294-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"A biologic risk model for stage I lung cancer : Immunohistochemical analysis of 408 patients with the use of ten molecular markers. Discussion\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Journal of thoracic and cardiovascular surgery\";s:9:\"\u0000*\u0000stitle\";s:27:\"J. thorac. cardiovasc. surg\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:3:\"117\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"736\";s:8:\"\u0000*\u0000epage\";s:3:\"743\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-5223\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"D'AMICO\";s:10:\"\u0000*\u0000aufirst\";s:4:\"T. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:9:\"MASSEY, M\";i:1;s:13:\"HERNDON, J. E\";i:2;s:11:\"MOORE, M.-B\";i:3;s:13:\"HARPOLE, D. H\";i:4;s:14:\"BENFIELD, J. R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JTCSAQ\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"A biologic risk model for stage I lung cancer : Immunohistochemical analysis of 408 patients with the use of ten molecular markers. Discussion\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
